The FDA usually follows the recommendations of its advisory panels.
Advisory panel members have been cleared of potential conflicts related to the meeting topic. Occasionally, a panelist is given a waiver, but no waivers were given at this meeting.
News
FDA panel unanimously backs cobas HPV test as primary screening tool
